5th to 9th October 2015, Bamako, Mali. Following the success of the first two “Vaccinology in Africa” courses held in Accra, Ghana (September 2013), and Nairobi Kenya (October 2014), this year’s annual course will be joint hosted by the Malaria Research and Training Centre (MRTC), Bamako Mali and ...
Just published - the report covers a summary of progress across the Institute's portfolio of research programmes and update on latest activities.
The Institute has expanded substantially in the last 10 years with several enlarging groups, strategic recruitments and a broadening base of funders from four continents. Recently, the Institute’s capacity to undertake small scale first-in-human trials very rapidly was illustrated by the request from the World Health Organization to undertake, with collaborators, the first trial of a new Ebola vaccine destined for West Africa in the 2014 outbreak.
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University. The first volunteers of the trial at Centre Hospitalier Universitaire le Dantec in Dakar received an initial vaccination at the start of July, with a booster vaccination one week later. While this is a short timescale for immunisation, if proved successful it would provide an option to respond to an Ebola outbreak with a rapid vaccination programme.
LONDON, June 15 (Reuters) - Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine that could have protected those now falling sick and dying in South Korea. "The question is: How long are we going to wait around and just follow these outbreaks before we get serious about making vaccines?" said Adrian Hill, a professor and director at the Jenner Institute at Britain's Oxford University.
South Africa stands at the centre of a global TB epidemic devastating the health of millions and their communities. Oxford University is working with South African researchers, health workers and community volunteers in the hunt for an urgently-needed new vaccine. Professor Helen McShane, Jenner Investigator, has been working with local and international organisations to build a system of trialling vaccines, with the active participation of the local community.
This one day Workshop is being co-hosted by Professor Gary Entrican on 27th October at the Moredun Institute, Edinburgh. It will include a range of presentations focusing on career development in veterinary vaccinology, providing complementary perspectives from funders and successful grant winners. The workshop is designed to educate and provide skills for early career researchers to develop their careers within vaccinology.
Antigen Discovery and Proteomics of Host Response workshop, hosted at the University of Liverpool on 18th November 2015.
The workshop will be hosted at the Foresight Centre and will include a range of presentations focusing on antigen discovery and the proteomics of host response, providing complementary perspectives of both research of the antigen and host response.This workshop is designed to educate researchers in the latest updates on antigen discovery and proteomics of host response as well as the tools and technologies to be able to conduct such research.
A vaccine against Malaria, developed at the Jenner Institute, has shown promising results in its first field trial. The trial in Kenya found that the vaccine was 67% effective against Plasmodium falciparum infections - see BBC report.
This year’s World Health Organisation (WHO) World Malaria Day (on 25th April) has the theme of ‘Defeat Malaria’. Nearly half the world’s population is at risk of contracting the disease, and millions are affected by malaria every year. Dr Sumi Biswas work on developing vaccines that block the blood transmission of malaria has won her a Grand Challenges Explorations Award.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.